Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study. Stasiolek M, Linker RA, Hayardeny L, Barilan O, Gold R Immun Inflamm Dis. 2015 Jun; 3(2):45-55. Epub 2015 Mar 04. PMID: 26029365. Abstract CommentRecommendBookmarkWatch